BLUEMSEYOUTH’s Post

🧬 Mast Cell Disease Awareness Day 🧬 Did you know that people with mast cell diseases experience symptoms due to overly active mast cells? These cells release histamine and other chemicals, leading to various reactions. While allergies to food, insects, or medications involve antibodies that trigger these reactions, mast cell diseases are different! 🚨 Learn more about mast cell disease and how it's managed from board-certified allergist Leena Padhye, MD in our latest Ask the Allergist video in collaboration with American College of Allergy, Asthma and Immunology (ACAAI)! 🎥 🎯 Stay informed and take control of your health. https://lnkd.in/ey-uB4Ua #MastCellDisease #MastCellAwareness #AskTheAllergist #AllergyCare #HistamineReactions

Exploration of Asthma & Allergy is a multidisciplinary journal that intends to publish papers of the highest quality, significance and innovativeness in all aspects of Asthma & Allergy. Priority is given to work providing innovative and original data or views in the field of molecular and immune mechanisms; molecular, functional and clinical diagnosis, management and treatment of asthma and related disorders. Special Interests will focus on allergic and immunological diseases of Upper Airways, Gastrointestinal Tract, Skin, Eye, Allergen specific ImmunoTherapy, and other disease modifying treatments, etc. Multidisciplinary views concerning Asthma & Allergic diseases diagnosis/management and treatment will be highly considered. Below are some manuscript sections: Welcome to submit your article to our journal through https://lnkd.in/gpUKsNfZ

Exploration of Asthma & Allergy is a multidisciplinary journal that intends to publish papers of the highest quality, significance and innovativeness in all aspects of Asthma & Allergy. Priority is given to work providing innovative and original data or views in the field of molecular and immune mechanisms; molecular, functional and clinical diagnosis, management and treatment of asthma and related disorders. Special Interests will focus on allergic and immunological diseases of Upper Airways, Gastrointestinal Tract, Skin, Eye, Allergen specific ImmunoTherapy, and other disease modifying treatments, etc. Multidisciplinary views concerning Asthma & Allergic diseases diagnosis/management and treatment will be highly considered. Below are some manuscript sections: Welcome to submit your article to our journal through https://lnkd.in/gpUKsNfZ

I congratulate David E. Melon, MD, FACS ‘s thesis acceptance and publication in this month’s Laryngoscope highlighting our private practice’s effort to apply patient journey mapping and care coordination strategies within allergy immunotherapy treatment for chronic disease management of inhalant allergies. https://lnkd.in/eB-8EHzU Core in the study’s finding was the ability to achieve robust high frequency patient engagement data capture achieving survey response rates of over 80% within the collection of over 61,000 survey questions within the study period. The application of electronic health survey instruments, patient reported outcomes, and other measures must have relevance to the patient’s own clinical care goals in order to achieve meaningful response rates for analytical power in future care coordination and patient journey strategies. Automated survey distribution and triggered clinical engagement points driven by patient responses relating to the care they are receiving will be key for successful chronic disease management within future value based care clinical pathways. #patientexpeience #patientjourneymapping #chronicdisease #valuebasedcare #carecoordination

September Marks Peak Asthma Season for Kids 🌿🏥📚 As summer ends and children head back to school, experts are warning parents about the rise in asthma cases. Dr. Gailen Marshall, president of the American College of Allergy, Asthma and Immunology, highlights September as a peak month due to increased exposure to viruses, environmental allergens like mold and ragweed, and disruptions in asthma management routines. Allergists often see a spike in asthma attacks and hospitalizations among children during this time. It's crucial for parents to ensure their kids are following their asthma management plans and stay vigilant against potential triggers. #AsthmaAwareness #BackToSchool #AllergySeason https://lnkd.in/d86Gti6Z

The December National Asthma News is out now. Access the essential round up of the National Asthma Council Australia's most popular resources this year and an overview of new releases in 2024. This includes medication charts, information papers for health professionals, new how-to videos and consumer fact sheets. Learn more about #ChristmasTreeSyndrome and how to maintain good asthma and allergy management over the holiday period. Access our latest Pollen and Allergies Podcast about sleep and asthma, the new E-cigarette and Vaping Cessation Guide published by Queensland Respiratory and Sleep Clinical Network, and Australasian Society of Clinical Immunology and Allergy's Anaphylaxis Training Refresher Video. Don't miss out on important asthma news and updates. Subscribe today: https://lnkd.in/gky7u_yT

Attention all researchers studying allergy, asthma, arthritis, inflammatory bowel disease, and various cancers. You are invited to join us next week for a webinar by BPS Bioscience Inc. on Deciphering the Roles of TSLP, TL1A, and OX40 Signaling Pathways in Inflammatory Diseases. Tuesday 11th June, 10am AEST Register at this link https://lnkd.in/e6yphpTA #inflammatorydiseases #inflammation #signalingpathways #TSLP #OX40 #TL1A

Immune signatures predict response to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis. First author: Nan Wang; corresponding authors: Yin Yao, Zheng Liu Read the article here: doi.org/10.1111/all.16068 In allergic #rhinitis (AR) patients undergoing house dust mite subcutaneous immunotherapy (HDM SCIT), distinct clinical and immune features are observed between responders and nonresponders prior to treatment. A model with a combination of baseline sIgE/tIgE ratio, TFR/TFH2 cell ratio, and CD23+ BSM frequency exhibits a strong predictive value for SCIT efficacy, as evidenced by a 12-month posttreatment assessment. The efficacy of this model is validated in an independent cohort. #Allergy_journal Read more articles published in Allergy on #immunotherapy here: https://lnkd.in/dVsjXuR8 https://lnkd.in/gXSmW89Y is a link to the April issue table of contents.

I have been on all sides of a clinical trial. Clinical trials must be a health care option. 1. When I was young - My mom consented for me to be in a clinical trial from age 4 to 17. 2. I wrote a protocol as a new Clinical Researcher. I tried to consent my 1st patient & the patient informed me the protocol was not patient friendly. I learned the importance of Patient Co-Creation of a Clinical Trial Protocol. 3. I have consented as an adult to be a part of a clinical trial. 4. Even though today is Clinical Trials Awareness Day, there are many ways People can engage in research. a. Provide patient and caregiver insights about living with a condition. b. Provide insights about a study protocol and patient participation c. Participate in an disease or condition specific education study. d. Provide insights about new medication options e. Provide expertise to studies f. Help write and review clinical trial summaries for patients. There are many more places patient ans caregiver partners can participate. If you have questions about participating, give me a shout!